Author: Derek Michalski, Chief Editor.
The clean-molecules investment market has entered a more disciplined phase. Capital is still available for hydrogen, ammonia, e-methanol and sustainable aviation fuel (SAF), but investors are becoming far more selective about the projects and technologies to which they commit it.
The distinction is increasingly between capital availability and capital deployability. A large development pipeline does not constitute an investable asset. For banks and infrastructure funds, the decisive variables are increasingly contracted revenues, counterparty quality, technology maturity, input-cost exposure, construction risk, regulatory support and the sponsor’s ability to absorb cost overruns and delays.
Dorian de Kermadec, Managing Director of Low Carbon Advisory at BBVA, puts the issue directly. “At BBVA, we see a real appetite from the sector to invest in hydrogen assets,” he says. But he adds that “the immaturity of the sector is limiting the ability of projects to secure financing.” BBVA identifies high green-hydrogen costs, limited offtaker appetite, evolving regulation and the complexity of integrating renewable generation, electrolysis and downstream products such as e-ammonia and e-methanol among the principal financing challenges.
The result is a market in which investors are increasingly rewarding de-risking rather than scale alone.
Bankability Is Becoming the Core Investment Metric
The most revealing projects are those that have progressed beyond development announcements and into financial close.
The US$650 million Villeta green-hydrogen fertiliser project in Paraguay is a case in point. Developed by ATOME Energy, it will use more than 100 MW of electrolysis powered by Paraguay’s renewable hydropower to produce hydrogen, convert it to ammonia and manufacture approximately 260,000 tonnes per year of calcium ammonium nitrate fertiliser.
More importantly for investors, the project has reached non-recourse financial close with the European Investment Bank, IDB Invest, IFC and FMO among the lenders. DNV acted as lender technical adviser.
Brice Le Gallo, DNV’s Vice President and Regional Director for Southern Europe, MEA and LATAM, describes the project as demonstrating that industrial-scale green hydrogen and fertiliser production can be “technically robust and financially viable under a project finance scheme”. DNV’s Regional Hydrogen Team Leader Guillermo Matute adds that “well-structured green hydrogen and derivative projects can become bankable and attract major international lenders in the short term”.
The significance lies in the structure rather than the headline capacity. Hydrogen is not being financed as a speculative commodity bet. It is embedded in a downstream industrial product with an identifiable market and a financing structure in which lenders can assess the entire value chain.
That is the model investors increasingly want to replicate.
Hydrogen Is Being Valued Through Its Revenue Architecture
The same logic is emerging in Europe.
BBVA’s financing of Basque Hydrogen in Bilbao represents the first project-finance loan for a renewable-hydrogen plant in the Iberian Peninsula. The project, developed by Petronor, Enagás Renovables and the Basque Energy Cluster, produces electrolytic hydrogen for synthetic fuels.
The importance of the transaction is that hydrogen is being evaluated as part of an integrated industrial value chain rather than as a standalone molecule. BBVA acted as financial adviser and debt coordinator, with the financing structured around an industrial end-use.
This is becoming a critical distinction for developers seeking institutional capital. A project producing hydrogen without a sufficiently robust offtake structure carries commodity-price risk. A project integrated into an e-fuel, fertiliser, refinery or chemical value chain can potentially allocate that risk through long-term contracts.
For lenders, that changes debt-service visibility. For private equity, it can materially change the valuation of the development platform.
Green Ammonia: The Offtake Test
Green ammonia is facing the same investment discipline, but at a larger industrial scale. The attraction is obvious. Existing ammonia infrastructure, global trading markets and established demand in fertiliser create a substantially more developed market than that for pure hydrogen. The problem is the premium.
Green ammonia remains dependent on renewable electricity costs, electrolyser utilisation, certification and the willingness of industrial customers or shipping companies to pay for lower-carbon production.
The AM Green project at Kakinada in India illustrates the scale of capital being considered. The development is planned at approximately 1.1 million tonnes per year of green ammonia capacity, with financing involving the Asian Development Bank and a broader institutional and strategic capital base.
But the underlying investment proposition still depends on securing long-term offtake. That is the critical point: production capacity has little value without sufficiently bankable demand.
The market is therefore beginning to distinguish between ammonia projects designed around an identified industrial customer and projects whose business case depends on a future green-ammonia premium that has yet to be established.
E-Methanol Moves Closer to Infrastructure Finance
E-methanol is attracting strategic capital because it provides an additional route into shipping fuel and chemical markets.
The Kassø Power-to-X facility in Denmark illustrates the transition. Developed by European Energy and Mitsui, the facility has approximately 42,000 tonnes per year of e-methanol production capacity and integrates renewable power, hydrogen production and CO₂ utilisation. Its offtake structure includes major industrial customers, providing a commercial foundation beyond the speculative hydrogen market.
This matters because e-methanol projects are exposed simultaneously to electricity prices, electrolyser utilisation, CO₂ availability, synthesis efficiency and downstream fuel prices. Investors therefore have to underwrite the entire chain.
The strategic opportunity is nevertheless significant. If e-methanol gains durable traction in maritime fuel markets, developers with operating assets, contracted offtake and proven integration capability could become acquisition targets for energy companies, shipping groups, commodity traders and infrastructure investors.
That makes strategic optionality an increasingly important component of technology valuation.
SAF Offers a Clearer Route to Bankability
SAF currently provides perhaps the clearest example of how regulation and corporate offtake can create an investable clean-fuels market.
Standard Chartered’s financing of SkyNRG’s Delfzijl SAF facility in the Netherlands is instructive. The greenfield project has reached financial close and is expected to produce 100,000 tonnes of SAF annually from 2028. KLM has contracted to take 75% of production.
James Richards, Executive Director of Infrastructure Development Finance at Standard Chartered, says the project combines “the key elements required to finance SAF at scale”: long-term predictable revenue, experienced infrastructure sponsors and alignment with European regulation. He argues that the structure demonstrates how “thoughtful risk allocation can turn an emerging technology into a bankable asset class”.
That is precisely the shift taking place across clean molecules.
The technology itself is no longer sufficient to attract project capital. Investors need visibility over the cash-flow profile generated once the plant is operational.
Standard Chartered’s wider analysis identifies price as the principal constraint on SAF scale-up, despite strengthening regulatory demand.
For project financiers, this creates a familiar infrastructure equation: regulation establishes demand, offtake contracts provide revenue visibility, sponsors contribute industrial expertise and lenders assess whether the resulting cash flows can support leverage.
Technology Risk Is Being Separated From Asset Risk
The investment hierarchy is also changing. Venture capital can tolerate technological uncertainty because it is investing relatively small amounts for potentially asymmetric returns. A technology company developing a more efficient electrolyser, ammonia cracker, CO₂ conversion process or SAF pathway can therefore still attract growth capital without having a fully bankable project.
Project finance is fundamentally different. Once hundreds of millions of euros are being committed to a plant, investors require performance guarantees, warranties, degradation assumptions, EPC certainty and evidence that the technology can operate at the required capacity factor.
This is why strategic investors are increasingly important. Industrial companies can provide more than equity. They can provide feedstock, offtake, engineering capability, operational expertise and ultimately a potential exit.
For founders, the implication is significant. The relevant valuation question is no longer simply the total addressable market.
It is how much capital is required to reach the next technical and commercial de-risking milestone.
A technology capable of reaching commercial demonstration with €20 million may be more attractive to a strategic investor than one requiring €200 million before its economics can be validated.
The Capital Stack Is Becoming More Sophisticated
The clean-molecules market is consequently developing a more differentiated capital stack.
Early-stage technology risk belongs primarily with venture capital and strategic corporate investors. Development risk can be absorbed by specialist infrastructure investors, growth equity and industrial sponsors. Once permits, offtake, technology and EPC arrangements are sufficiently advanced, project finance becomes possible. Operating assets can subsequently attract infrastructure funds, pension capital and lower-cost refinancing.
The implication is that developers should not treat financing as a single transaction. The optimal strategy is increasingly to move risk from one capital provider to another as the project matures.
Villeta demonstrates this at project level. Bilbao demonstrates it at industrial-hydrogen level. Kassø illustrates it in e-methanol. Delfzijl shows how contracted airline demand can support SAF project finance.
The common denominator is not technology. It is risk allocation.
Investors Are Buying Cash-Flow Visibility
The clean-molecules market is therefore not experiencing a withdrawal of capital. It is undergoing a repricing of risk.
Investors are increasingly asking five questions before assigning meaningful value to a project or platform:
Who buys the product? What protects the project from electricity, feedstock and commodity-price volatility? Is the technology sufficiently mature to support debt? How much equity is required before cash generation? Who is the natural buyer of the asset or technology once it is de-risked?
Those questions are pushing the market away from gigawatt announcements and towards contracted capacity, bankable revenues and demonstrable project execution.
For hydrogen, the strongest opportunities are increasingly those connected to industrial demand. For ammonia, the decisive variable is the development of durable green-product markets. For e-methanol, strategic value lies in the ability to integrate renewable power, hydrogen and CO₂ into a commercially competitive fuel. For SAF, regulation and airline offtake are creating perhaps the clearest route from policy support to infrastructure finance.
The investment environment is therefore becoming more conventional, not less.
Capital remains available. But it is increasingly flowing towards projects where technology risk can be quantified, revenue risk can be allocated and capital can ultimately be returned.
That is the new dividing line between a clean-molecules project that is merely announced and one that is genuinely financeable.
